[HTML][HTML] Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (CovishieldTM) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021

S Murali, M Sakthivel, K Pattabi, V Venkatasamy… - Vaccines, 2022 - mdpi.com
We estimated the effectiveness of two doses of the ChAdOx1 nCoV-19 (Covishield) vaccine
against any COVID-19 infection among individuals ≥45 years in Chennai, Tamil Nadu, India…

[PDF][PDF] Brucellosis among fever patients attending a primary health centre in rural South India

…, K Thiyagarajan, ST Ganesan, S Kalyanaraman… - The Journal of Infection …, 2023 - jidc.org
… However, our estimate of brucellosis was similar to what is reported elsewhere in India [5–8].
These reports are either from occupationally … Dhana Priya Vadhani S in laboratory testing. …

Prevalence of Haemoglobinopathies Among Malayali Tribes of Jawadhu Hills, Tiruvannamalai District, Tamil Nadu, India: A Community-Based Cross-Sectional Study

…, A Nadkarni, S Rajasubramaniam… - … District, Tamil Nadu …, 2023 - papers.ssrn.com
Background: Hemoglobin (Hb), a red pigment of red blood cells (RBCs) carries oxygen from
the lungs to different organs of the body and transports carbon dioxide back to the lungs. …

[HTML][HTML] Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

…, S Narasimhaiah, S Panda, S Pati, S Patil… - Indian Journal of …, 2020 - journals.lww.com
Methods: From May 11 to June 4, 2020, a randomly sampled, community-based survey was
conducted in 700 villages/wards, selected from the 70 districts of the 21 States of India, …

Monitoring the trend of SARS-CoV-2 seroprevalence in Chennai, India, July and October 2020

…, V Saravanakumar, S Selvaraju… - Transactions of The …, 2021 - academic.oup.com
… The central region is the commercial centre and the southern region is the home to many
information technology industries. These regions were spared in the early phase of the …